Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Simon

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Current Opinion in Rheumatology|May 1, 1995
Actions and toxicity of nonsteroidal anti-inflammatory drugsL S Simon
Current Opinion in Rheumatology|May 1, 1993
Nonsteroidal anti-inflammatory drug toxicityL S Simon
Annals of the Rheumatic Diseases|October 16, 2002
Pharmacovigilance: towards a better understanding of the benefit to risk ratioL S Simon
Current Opinion in Rheumatology|June 1, 1990
Toxicity of nonsteroidal anti-inflammatory drugsL S Simon
The American Journal of Medicine|July 2, 1999
Role and regulation of cyclooxygenase-2 during inflammationL S Simon
Clinical Cornerstone|February 26, 2000
Osteoarthritis: a reviewL S Simon
Arthritis and Rheumatism|June 21, 2001
COX-2 inhibition: an advance or only pharmaceutical "hype"?L S Simon
Osteoarthritis and Cartilage|May 9, 2006
Osteoarthritis, imaging and guidance for approval of a structural "indication"L S Simon
Hospital Pharmacy|April 10, 1986
Role of the hospital pharmacy director in experiential educationL S Simon
Journal of the Peripheral Nervous System : JPNS|October 2, 2014
The regulatory perspectiveL S Simon
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Current Opinion in Rheumatology|May 1, 1995
Actions and toxicity of nonsteroidal anti-inflammatory drugsL S Simon
Current Opinion in Rheumatology|May 1, 1993
Nonsteroidal anti-inflammatory drug toxicityL S Simon
Annals of the Rheumatic Diseases|October 16, 2002
Pharmacovigilance: towards a better understanding of the benefit to risk ratioL S Simon
Current Opinion in Rheumatology|June 1, 1990
Toxicity of nonsteroidal anti-inflammatory drugsL S Simon
The American Journal of Medicine|July 2, 1999
Role and regulation of cyclooxygenase-2 during inflammationL S Simon
Clinical Cornerstone|February 26, 2000
Osteoarthritis: a reviewL S Simon
Arthritis and Rheumatism|June 21, 2001
COX-2 inhibition: an advance or only pharmaceutical "hype"?L S Simon
Osteoarthritis and Cartilage|May 9, 2006
Osteoarthritis, imaging and guidance for approval of a structural "indication"L S Simon
Hospital Pharmacy|April 10, 1986
Role of the hospital pharmacy director in experiential educationL S Simon
Journal of the Peripheral Nervous System : JPNS|October 2, 2014
The regulatory perspectiveL S Simon
Pageof 8